AVEO Pharmaceuticals (AVEO) Plans Stock Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts AVEO Hot Sheet
Join SI Premium – FREE
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering are to be sold by AVEO.
The proposed size of the offering was note disclosed.
J.P. Morgan Securities LLC is acting as sole book-running manager for the proposed offering, with RBC Capital Markets, LLC and Canaccord Genuity Inc. acting as co-lead managers.
The proposed size of the offering was note disclosed.
J.P. Morgan Securities LLC is acting as sole book-running manager for the proposed offering, with RBC Capital Markets, LLC and Canaccord Genuity Inc. acting as co-lead managers.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pirate Gold closes $13.6M brokered private placement
- Helio Corporation files to uplist to Nasdaq with 2M share offering
- GoldInxs Mining closes $1.25M private placement and adds directors
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
JPMorgan, RBC Capital, Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
